|
|
| Why next-generation ADC trials demand real-time visibility | The success of next-generation ADC trials depends on more than breakthrough science. Sponsors must navigate increasing operational complexity while protecting patient safety and maintaining study momentum. Learn how leading organizations are using proactive risk management, real-time clinical oversight and connected data platforms to accelerate decisions, reduce delays and improve the patient experience. Explore real-time ADC trial strategies. |
|
|
|
|
|
| Psychedelic Drug Trials: Are Your Sites Ready? | Case Study | Flourish Research | Psychedelic trials require unique operational approaches. Learn how to address patient safety, blinding, specialized assessments, and therapeutic setting considerations. |
|
|
|
| Participant Payment — Make It Make Cents | Guest Column | By T.J. Sharpe | Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden. |
|
|
| When Patient Burden Becomes A Retention Risk | Video | TruTechnologies | Patient burden is not theoretical. In this clip, we hear professional insight into why sponsors need to understand patient burden before a trial is underway. |
|
|
| Leading Rare Disease Research | Brochure | Ergomed Group | Rare disease trials demand specialized expertise. Learn how patient- and site-focused strategies can reduce burden, strengthen recruitment and retention, and support trial success. |
|
|
|
|
|
|
| Removing Barriers To Trial Participation | Video | Mural Health | Learn how one platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations worldwide. |
|
|
|
|
| Connect With Clinical Leader: |
|
|
|
